ARCHIVES

Xgeva Significantly Increases Bone Metastasis-Free Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

For Research Projects In Cancer Therapy

March 1, 1996

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009